106 related articles for article (PubMed ID: 18071117)
1. Oxidative stress change by systemic corticosteroid treatment among patients having active graves ophthalmopathy.
Tsai CC; Kao SC; Cheng CY; Kau HC; Hsu WM; Lee CF; Wei YH
Arch Ophthalmol; 2007 Dec; 125(12):1652-6. PubMed ID: 18071117
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress in patients with Graves' ophthalmopathy: relationship between oxidative DNA damage and clinical evolution.
Tsai CC; Cheng CY; Liu CY; Kao SC; Kau HC; Hsu WM; Wei YH
Eye (Lond); 2009 Aug; 23(8):1725-30. PubMed ID: 18849914
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress markers in tears of patients with Graves' orbitopathy and their correlation with clinical activity score.
Choi W; Li Y; Ji YS; Yoon KC
BMC Ophthalmol; 2018 Nov; 18(1):303. PubMed ID: 30463536
[TBL] [Abstract][Full Text] [Related]
4. Analysis of oxidative stress expressed by urinary level of 8-hydroxy-2'-deoxyguanosine and biopyrrin in atrial fibrillation: effect of sinus rhythm restoration.
Toyama K; Yamabe H; Uemura T; Nagayoshi Y; Morihisa K; Koyama J; Kanazawa H; Hoshiyama T; Ogawa H
Int J Cardiol; 2013 Sep; 168(1):80-5. PubMed ID: 23040081
[TBL] [Abstract][Full Text] [Related]
5. [Urinary 8-hydroxy-2'-deoxyguanosin (8-OHdG) in patients with chronic liver diseases].
Ishizakai M; Yoshida K; Nishimoto N; Saleh AM; Ishii C; Handa H; Ogawara H; Nagamine T; Murakami M; Murakami H
Rinsho Byori; 2004 Sep; 52(9):732-6. PubMed ID: 15552932
[TBL] [Abstract][Full Text] [Related]
6. Pulsatile ocular blood flow change after treatment with systemic steroid in patients with Graves' ophthalmopathy.
Tsai CC; Kau HC; Tsai HH; Kao SC; Hsu WM
Eye (Lond); 2006 Sep; 20(9):1025-9. PubMed ID: 16123781
[TBL] [Abstract][Full Text] [Related]
7. Urinary 8-hydroxy-2'-deoxyguanosine excretion as a biomarker for estimating DNA oxidation in patients undergoing external radiotherapy and/or brachytherapy.
Yamazaki H; Inoue T; Koizumi M; Tanaka E; Yoshioka Y; Nakamura H; Shuo X; Inoue T
Oncol Rep; 2005 May; 13(5):847-51. PubMed ID: 15809748
[TBL] [Abstract][Full Text] [Related]
8. Urinary 8-hydroxy-2'-deoxyguanosine as a novel biomarker of inflammatory activity in patients with cardiac sarcoidosis.
Kobayashi S; Myoren T; Oda S; Inari M; Ishiguchi H; Murakami W; Fukuda M; Tanaka T; Okuda S; Nao T; Doi M; Yamada J; Okamura T; Hoshii Y; Suga K; Matsuzaki M; Yano M
Int J Cardiol; 2015; 190():319-28. PubMed ID: 25935620
[TBL] [Abstract][Full Text] [Related]
9. Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients.
Xu GW; Yao QH; Weng QF; Su BL; Zhang X; Xiong JH
J Pharm Biomed Anal; 2004 Sep; 36(1):101-4. PubMed ID: 15351053
[TBL] [Abstract][Full Text] [Related]
10. Soluble CD40 and its ligand CD154 in patients with Graves' ophthalmopathy during combined therapy with corticosteroids and teleradiotherapy.
Myśliwiec J; Waligórski D; Nikołajuk A; Górska M
Adv Med Sci; 2007; 52():104-8. PubMed ID: 18217399
[TBL] [Abstract][Full Text] [Related]
11. Serum gelatinases (MMP-2 and MMP-9) and VCAM-1 as a guideline in a therapeutic approach in Graves' ophthalmopathy.
Myśliwiec J; Adamczyk M; Pawłowski P; Nikołajuk A; Górska M
Endokrynol Pol; 2007; 58(2):105-9. PubMed ID: 17578825
[TBL] [Abstract][Full Text] [Related]
12. Increased serum VEGF and b-FGF in Graves' ophthalmopathy.
Ye X; Liu J; Wang Y; Bin L; Wang J
Graefes Arch Clin Exp Ophthalmol; 2014 Oct; 252(10):1639-44. PubMed ID: 24867311
[TBL] [Abstract][Full Text] [Related]
13. Effects of pulse methylprednisolone and oral methylprednisolone treatments on serum levels of oxidative stress markers in Graves' ophthalmopathy.
Akarsu E; Buyukhatipoglu H; Aktaran S; Kurtul N
Clin Endocrinol (Oxf); 2011 Jan; 74(1):118-24. PubMed ID: 21044110
[TBL] [Abstract][Full Text] [Related]
14. Circadian variation in multiple sclerosis of oxidative stress marker of DNA damage. A potential cancer marker?
Kanabrocki EL; Ryan MD; Murray D; Jacobs RW; Wang J; Hurder A; Friedman NC; Siegel G; Eladasari B; Nemchausky BA; Cornelissen G; Halberg F
Clin Ter; 2006; 157(2):117-22. PubMed ID: 16817500
[TBL] [Abstract][Full Text] [Related]
15. Assessment of oxidative stress due to exposure to pesticides in plasma and urine of traditional limited-resource farm workers: formation of the DNA-adduct 8-hydroxy-2-deoxy-guanosine (8-OHdG).
Tope AM; Panemangalore M
J Environ Sci Health B; 2007 Feb; 42(2):151-5. PubMed ID: 17365329
[TBL] [Abstract][Full Text] [Related]
16. Urinary 8-OHdG elevations in a partial lesion rat model of Parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion.
Kikuchi Y; Yasuhara T; Agari T; Kondo A; Kuramoto S; Kameda M; Kadota T; Baba T; Tajiri N; Wang F; Tayra JT; Liang H; Miyoshi Y; Borlongan CV; Date I
J Cell Physiol; 2011 May; 226(5):1390-8. PubMed ID: 20945350
[TBL] [Abstract][Full Text] [Related]
17. New biomarker evidence of oxidative DNA damage in whole saliva from clinically healthy and periodontally diseased individuals.
Takane M; Sugano N; Iwasaki H; Iwano Y; Shimizu N; Ito K
J Periodontol; 2002 May; 73(5):551-4. PubMed ID: 12027259
[TBL] [Abstract][Full Text] [Related]
18. Urinary 8-hydroxydeoxyguanosine levels as a biomarker for progression of Parkinson disease.
Sato S; Mizuno Y; Hattori N
Neurology; 2005 Mar; 64(6):1081-3. PubMed ID: 15781836
[TBL] [Abstract][Full Text] [Related]
19. Cross-sectional and longitudinal analysis of an oxidative stress biomarker for spinal and bulbar muscular atrophy.
Mano T; Katsuno M; Banno H; Suzuki K; Suga N; Hashizume A; Tanaka F; Sobue G
Muscle Nerve; 2012 Nov; 46(5):692-7. PubMed ID: 22941760
[TBL] [Abstract][Full Text] [Related]
20. Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids.
Bednarek J; Wysocki H; Sowiński J
Immunol Lett; 2004 May; 93(2-3):227-32. PubMed ID: 15158621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
